Showing results (511-520 of 537) with videos related to

Sort By:
Pageof 54
Gastroenterology|January 4, 2024
Global Prevalence of Helicobacter pylori Infection and Incidence of Gastric Cancer Between 1980 and 2022Yi-Chu Chen, Peter Malfertheiner, Hao-Ting Yu, et al.
United European Gastroenterology Journal|July 15, 2024
Skeletal muscle quality predicts overall survival in advanced liver hepatocellular carcinoma treated with SIRT and sorafenib: A subanalysis of the SORAMIC trialAlexey Surov, Andreas Wienke, Jan Borggrefe, et al.
Digestive Diseases (Basel, Switzerland)|April 29, 2026
Bone mineral density does not predict overall survival in patients with advanced hepatocellular carcinoma: A subanalysis of the SORAMIC trialMaximilian Thormann, Andreas Wienke, Ricarda Seidensticker, et al.
European Journal of Cancer (Oxford, England : 1990)|June 8, 2017
Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib: Patient-focused outcome results from the randomised phase III REACH studyIan Chau, Markus Peck-Radosavljevic, Christophe Borg, et al.
Digestion|February 19, 2025
Impact of Helicobacter pylori on Immune Checkpoint Inhibition in Hepatocellular Carcinoma: A Multicenter StudyNajib Ben Khaled, Christian Schulz, Marianna Alunni-Fabbroni, et al.
Journal of Cachexia, Sarcopenia and Muscle|August 18, 2023
Prognostic role of radiomics-based body composition analysis for the 1-year survival for hepatocellular carcinoma patientsSylvia Saalfeld, Robert Kreher, Georg Hille, et al.
JAMA Oncology|September 23, 2016
Ramucirumab as Second-Line Treatment in Patients With Advanced Hepatocellular Carcinoma: Analysis of REACH Trial Results by Child-Pugh ScoreAndrew X Zhu, Ari David Baron, Peter Malfertheiner, et al.
Hepatology Communications|May 23, 2023
Impact of body composition in advanced hepatocellular carcinoma: A subanalysis of the SORAMIC trialAlexey Surov, Maximilian Thormann, Mattes Hinnerichs, et al.
Gut|January 15, 2017
European consensus conference on faecal microbiota transplantation in clinical practiceGiovanni Cammarota, Gianluca Ianiro, Herbert Tilg, et al.
United European Gastroenterology Journal|November 12, 2020
European Registry on Helicobacter pylori management: Single-capsule bismuth quadruple therapy is effective in real-world clinical practiceOlga P Nyssen, Angeles Perez-Aisa, Manuel Castro-Fernandez, et al.
Pageof 54